Skip to main content

Table 5 Intraoperative serum levels of GFAP and UCHL1

From: Effects of intraoperative lung-protective ventilation on clinical outcomes in patients with traumatic brain injury: a randomized controlled trial

   Group A (n = 25) Group B (n = 28) Group C (n = 26) P
GFAP T1 328.68 ± 54.50 325.79 ± 55.82 336.58 ± 61.04 0.776
T2 399.16 ± 55.40* 360.93 ± 56.71a* 389.12 ± 57.32* 0.042
T3 459.24 ± 56.37*# 396.68 ± 55.78a*# 431.96 ± 71.44b*# 0.002
UCHL1 T1 422.60 ± 165.27 413.43 ± 172.77 434.58 ± 186.98 0.906
T2 828.16 ± 134.20* 661.96 ± 166.73a* 782.00 ± 177.36b* 0.001
T3 1223.00 ± 126.37*# 849.21 ± 175.51a*# 1068.50 ± 167.71ab*# < 0.001
  1. Data are presented as the mean ± standard deviation (pg/mL)
  2. GFAP glial fibrillary acidic protein; UCHL1 ubiquitin carboxyl-terminal hydrolase isozyme L1
  3. aP<0.05 compared to Group A, bP<0.05 compared to Group B at the same point in time
  4. *P < 0.05, #P < 0.05 compared to T1 and T2 within each group